Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/02/1998 | CN1200723A New (3-alkoxy-phenoxy)-ethyl] dialkylamine derivatives and their use as local anaesthetics |
12/02/1998 | CN1200720A Carboxylic acid derivatives, their prepn. and their use |
12/02/1998 | CN1200677A Solid mixtures of cyclodextrins prepd. via melt-extrusion |
12/02/1998 | CN1200676A Pharmaceutical compositions contg. platelet aggregation inhibitors |
12/02/1998 | CN1200673A Eye drops |
12/02/1998 | CN1200672A Pharmaceutical formulation |
12/02/1998 | CN1200671A Topically applied structural cellulite treatment |
12/02/1998 | CN1200670A Pharmaceutical compositions contg. hydroximic acid derivatives |
12/02/1998 | CN1200669A Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
12/02/1998 | CN1200653A Cancer chemoprotective food products |
12/02/1998 | CN1200374A Vitronectin receptor antagonists, their prepn. and their use |
12/02/1998 | CN1200373A Vitronectin receptor antagonists, their prepn. and use |
12/02/1998 | CN1200366A Neo-L-threonic acid derivatives |
12/02/1998 | CN1200297A Phospholipid composite, prepn. method and application thereof |
12/02/1998 | CN1200277A Compound oral liquid medicine for treating psychosis and nerve system disease |
12/02/1998 | CN1200276A Medicine for lowering blood-sugar and nourishing the heart and method for preparing same |
12/02/1998 | CN1200269A Medicine for treating hypertensional sickness |
12/02/1998 | CN1200268A New topical prepn. for treatment of erectile dystunction |
12/02/1998 | CN1200267A Compound ointment for preventing and treating cold injury and chilblain |
12/02/1998 | CN1200266A Method for preparing anti-cancer medicine using beta-elemene as main effective ingredient, and components of the medicine |
12/02/1998 | CN1200250A Functional food for lowering blood-sugar, blood-lipid and blood-presure |
12/02/1998 | CN1040985C Method for prepn. of benzo-aza-tropilidene compound |
12/02/1998 | CN1040984C Liponucleotide of seco-nucleosides, process for preparing same and pharmaceutical composition with anti-viral action contg. same |
12/02/1998 | CN1040982C Method for preparing pyranoquinoline and salts thereof |
12/02/1998 | CN1040980C Second messenger cell signaling inhibitors |
12/02/1998 | CN1040979C Antipsychotic method |
12/02/1998 | CN1040949C Medicine for delivery and abortion and its prepn. method |
12/02/1998 | CN1040947C Prepn. of synergia fluorouracil and its derivant tegafur suppository |
12/02/1998 | CN1040945C Process for preparing chloroformyl diphosphate |
12/02/1998 | CA2238580A1 Cell adhesion inhibitors |
12/02/1998 | CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene |
12/01/1998 | US5844106 Modified oligonucleotides, their preparation and their use |
12/01/1998 | US5844104 Method of preparing a composition containing a high amount of ganglioside |
12/01/1998 | US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto |
12/01/1998 | US5844061 Polyphenol derivative compositions and perparation thereof |
12/01/1998 | US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
12/01/1998 | US5844003 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
12/01/1998 | US5844002 Method for inducing bronchodilation using optically pure R(-) albuterol |
12/01/1998 | US5844001 Combination platinum chemotherapeutic/antiestrogen therapy for human cancers |
12/01/1998 | US5843999 2-phenylazulene derivatives and a manufacturing method of these compounds |
12/01/1998 | US5843998 Skin blemish treatment |
12/01/1998 | US5843997 Excitatory amino acid receptor antagonists |
12/01/1998 | US5843996 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution |
12/01/1998 | US5843994 Compositions and methods for treating and preventing pathologies including cancer |
12/01/1998 | US5843993 Hydroxyalkyl phosphine gold complexes for use as diagnostic and therapeutic pharmaceuticals and method of making same |
12/01/1998 | US5843989 C4 -amide substituted compounds and their use as therapeutic agents |
12/01/1998 | US5843988 Cyclopropachromencarboxylic acid derivatives |
12/01/1998 | US5843987 Method of stimulating gastrointestinal motility with ellagic acid |
12/01/1998 | US5843986 Tricyclic amide compounds |
12/01/1998 | US5843984 Sulfated benzothiophene derivatives, methods of use and formulations containing same |
12/01/1998 | US5843983 Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use |
12/01/1998 | US5843980 Benzamidoxime prodrugs as antipneumocystic agents |
12/01/1998 | US5843979 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
12/01/1998 | US5843977 (3-heteroaryl-1-pyrrolidinyl) alkoxy!-3,4-dihydro-1(2H)-naphthalenones and related compounds and their therapeutic utility |
12/01/1998 | US5843976 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
12/01/1998 | US5843975 Oxazolidinone derivatives, their preparation and therapeutical use |
12/01/1998 | US5843974 Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se |
12/01/1998 | US5843973 Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient |
12/01/1998 | US5843972 Heterocyclic β-adrenergic agonists |
12/01/1998 | US5843971 1, 1-BIS (heteroazolyl) alkane derivatives and their use as neuroprotective agents |
12/01/1998 | US5843970 Thiazolidine derivatives for the treatment of hypertension |
12/01/1998 | US5843969 Protecting agent for organ or tissue |
12/01/1998 | US5843968 Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
12/01/1998 | US5843967 6-membered nitrogen-containing heteroaryl-oxazolidinones |
12/01/1998 | US5843966 Piperidine derivatives |
12/01/1998 | US5843965 Benzo B! thiophene compounds, intermediates, processes, compositions, and methods |
12/01/1998 | US5843964 Methods of inhibiting endometrial mitoses |
12/01/1998 | US5843963 Benzothiophene compounds, intermediates, processes, compositions, and methods |
12/01/1998 | US5843962 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
12/01/1998 | US5843961 Method and composition for treating erectile dysfunction |
12/01/1998 | US5843960 Inhibitors of rotamase enzyme activity |
12/01/1998 | US5843959 Methods and bicyclic polyamine compositions for the treatment of inflammation |
12/01/1998 | US5843957 Naphthyridine derivatives |
12/01/1998 | US5843956 Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof |
12/01/1998 | US5843954 Camptothecin derivatives, preparations thereof and antitumor agents |
12/01/1998 | US5843953 7-substituted 4-aza cholanic acid derivatives and their use |
12/01/1998 | US5843949 1-(1H-indolyloxyalkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
12/01/1998 | US5843948 Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising them |
12/01/1998 | US5843947 N-pyridyl carboxamides and derivatives |
12/01/1998 | US5843946 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
12/01/1998 | US5843943 Compounds for inhibition of ceramide-mediated signal transduction |
12/01/1998 | US5843942 Aromatic amino ethers as pain relieving agents |
12/01/1998 | US5843941 Ras farnesyl transferase inhibitors |
12/01/1998 | US5843940 Benzothiophene compounds, compositions, and method |
12/01/1998 | US5843939 Derivatives of 3-bromo- and 3,3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
12/01/1998 | US5843938 Treatment of atherosclerosis |
12/01/1998 | US5843937 DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
12/01/1998 | US5843936 Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes |
12/01/1998 | US5843935 Protein kinase C inhibitors |
12/01/1998 | US5843934 Uses of estrogen compounds for the treatment of disease |
12/01/1998 | US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
12/01/1998 | US5843932 Therapeutic methods and delivery systems utilizing sex steroid precursors |
12/01/1998 | US5843931 6,7-modified 11β-aryl-4-oestrenes |
12/01/1998 | US5843930 Aqueous suspension with hydrolyzed polyvinyl alcohol viscosity modifier, non-ototoxic benzyl alcohol preservative, a polysorbate, and lecithin |
12/01/1998 | US5843929 Chemoprevention of metachronous adenomatous colorectal polyps |
12/01/1998 | US5843928 2-alkylidene-19-nor-vitamin D compounds |
12/01/1998 | US5843927 18,19-dinor-vitamin D compounds |
12/01/1998 | US5843926 Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
12/01/1998 | US5843925 Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
12/01/1998 | US5843924 Intravenous alendronate formulations |